http://www.mmm-online.com/healthcare-reform/topic/2075/ Articles tagged with Healthcare Reform from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no The effectiveness of new drugs is in decline, says an analysis, and researchers say comparative studies should look beyond efficacy measures. http://www.mmm-online.com/pill-plus-value-adds-beat-brand-names-in-the-age-of-acos/article/297136/ Mon, 10 Jun 2013 17:08:45 GMT The effectiveness of new drugs is in decline, says an analysis, and researchers say comparative studies should look beyond efficacy measures. MMM Healthcare critics continue to spend on anti-ACA ads; Janssen plunges into the microbiome; Lilly gets adult ADHD indication in UK; Sanofi pulls two drugs; and Aveo lays off 140. http://www.mmm-online.com/business-briefs-kantar-media-janssen-eli-lilly-boehringer-ingelheim-sanofi-aveo/article/296505/ Wed, 05 Jun 2013 17:47:38 GMT Healthcare critics continue to spend on anti-ACA ads; Janssen plunges into the microbiome; Lilly gets adult ADHD indication in UK; Sanofi pulls two drugs; and Aveo lays off 140. MMM JAMA's look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients. http://www.mmm-online.com/impact-and-importance-of-patient-preference-still-tbd/article/295377/ Wed, 29 May 2013 17:03:52 GMT JAMA's look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients. MMM Amgen and Astellas team up to take on Japan; GSK acquires Swiss vaccine developer's innovative platform; Ireland makes generic switches easier; Novo backs wet AMD therapy; Nike ditches Livestrong http://www.mmm-online.com/business-briefs-amgen-and-astellas-gsk-teva-novo-livestrong/article/295369/ Wed, 29 May 2013 16:33:31 GMT Amgen and Astellas team up to take on Japan; GSK acquires Swiss vaccine developer's innovative platform; Ireland makes generic switches easier; Novo backs wet AMD therapy; Nike ditches Livestrong MMM The agency is revisiting the impact DTC advertising can have on healthcare. What's new: NPs and PAs are being asked for input. http://www.mmm-online.com/fda-widens-scope-of-dtc-impact-survey/article/290187/ Tue, 23 Apr 2013 16:58:12 GMT The agency is revisiting the impact DTC advertising can have on healthcare. What's new: NPs and PAs are being asked for input. MMM Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer. http://www.mmm-online.com/consumers-must-make-own-choices-as-health-guidelines-change/article/289607/ Fri, 19 Apr 2013 16:06:11 GMT Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer. MMM Internet trends show fondness for online health information, but no need for docs to take on a third job, Millennium says diabetes device market to grow moderately over five years. http://www.mmm-online.com/company-news-mccann-millennium-research-group/article/276346/ Wed, 16 Jan 2013 18:45:50 GMT Internet trends show fondness for online health information, but no need for docs to take on a third job, Millennium says diabetes device market to grow moderately over five years. MMM From FDA and pharma, to Caronia and off-label communication, three healthcare policy experts offer their take on what 2013 holds in store. http://www.mmm-online.com/the-year-ahead-a-capitol-bit-of-crystal-ball-gazing/article/273883/ Wed, 26 Dec 2012 16:45:14 GMT From FDA and pharma, to Caronia and off-label communication, three healthcare policy experts offer their take on what 2013 holds in store. MMM Biogen Idec sets aside $10M for ALS research, HHS clears eight exchanges. http://www.mmm-online.com/company-news-biogen-idec-hhs-televox/article/273542/ Thu, 20 Dec 2012 18:22:20 GMT Biogen Idec sets aside $10M for ALS research, HHS clears eight exchanges. MMM AstaZeneca avoids a Lipitor moment, FDA approves Novartis med for Cushing's, and Teva ventures into South Korea. Plus: a closer look at health exchanges http://www.mmm-online.com/company-news-astrazeneca-novartis-teva/article/272860/ Mon, 17 Dec 2012 17:17:53 GMT AstaZeneca avoids a Lipitor moment, FDA approves Novartis med for Cushing's, and Teva ventures into South Korea. Plus: a closer look at health exchanges MMM